Skip to main content

Advertisement

Table 2 Clinical characteristics of patients, S100A7 expression and the survival analysis

From: RETRACTED ARTICLE: Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans

  S100A7 experssion Log rank Median Log rank Cox regression  
Factors +(n) -(n) P Total Survival Subgroup Univariate Multivariate
P (Months) P HR 95 % CI P HR 95% CI P
Gender    0.304 0.274         
Female (n = 38) 14 24    57.12 0.075       
Male (n = 105) 63 42    59.20 0.024       
Age    0.29 0.451         
<60y (n = 49) 30 19    59.13 0.146       
60y (n = 94) 57 37    52.24 0.018       
Tumor size    0.014 0.000         
T1+T2 (n = 92) 71 21    62.3 0.0026 2.128 1.38-3.472 0.002 1.563 1.028-2.859 0.047
T3+T4 (n = 51) 16 35    36.2 0.437       
Differentiation    0.473 0.269         
Low (n = 94) 62 32    52.8 0.016       
Moderate/high (n = 49) 25 24    60.5 0.162       
Lymph node    0.063 0.000    2.846 1.93-5.053 0.001 2.73 1.40-3.180 0.02
N0+N1 (n = 106) 69 37    61.5 0.012       
N2+N3 (n = 37) 18 19    30.8 0.165       
Distant M    0.258 0.684    1.235 0.63-2.158 0.392    
M0 (n = 131) 79 52    59.6 0.006       
M1(n = 12) 8 4    44.8 0.538       
Clinical stage    0.082 0.0013    2.35 1.364-3.86 0.001 0.93 0.435-1.132 0.876
I+II(n = 89) 49 40    615 0.038       
III+IV(n = 54) 38 16    37.9 0.026       
S100A7 (n = 143) 87 56 0.001 0.007 58.2/43.8   1.926 1.23-3.28 0004. 2.01 1.35-4.157 0.002